
POINT Biopharma Global Investor Relations Material
Latest events

Investor Day 2023
POINT Biopharma Global
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from POINT Biopharma Global Inc
Access all reports
POINT Biopharma Global Inc. is a radiopharmaceutical company focused on developing and commercializing radioligands for cancer treatment. The company aims to enhance precision oncology through a portfolio of targeted radioligand therapies, leveraging its in-house manufacturing capabilities and secured supplies of key medical isotopes. POINT Biopharma actively participates in clinical trials, such as the SPLASH trial for metastatic castration-resistant prostate cancer. The company is headquartered in Indianapolis, Indiana, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
PNT
Country
🇺🇸 United States